表紙
市場調查報告書
商品編碼
1088364

全球腫瘤信息系統(OIS)市場到2027預測:按產品/服務,應用,最終用戶(醫院/影像中心,消融/癌症治療中心,政府機構,研究機構),地區

Oncology Information System Market by Product and Service, Application, End User (Hospitals & diagnostic imaging centers, Ablation & Cancer Care Centers, Government Institutions and Research Facilities) - Global Forecast to 2027

出版日期: | 出版商: MarketsandMarkets | 英文 341 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

由於更高的醫療成本和癌症患者的增加,OIS 解決方案的採用率增加,預計腫瘤信息系統 (OIS) 市場將在預測期內強勁增長。

本報告研究和分析全球腫瘤信息系統 (OIS) 市場,並提供有關市場概況、行業趨勢、細分市場分析、競爭條件、主要參與者等的最新信息。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮

第 5 章市場概述

  • 市場動態
    • 促進因素
    • 抑制器
    • 機會
    • 挑戰

第6章行業考慮

  • 技術分析:腫瘤學信息系統 (OIS)
  • 價格分析:腫瘤學信息系統 (OIS)
  • 生態系統情況:腫瘤信息系統 (OIS) 市場
  • 監管分析
  • 監管機構、政府機構和其他組織
  • 波特五力分析
  • 主要利益相關者和採購標準
  • 關鍵採購標準:按最終用戶
  • 專利分析
  • 主要會議和活動
  • COVID-19 對腫瘤信息系統 (OIS) 市場的影響

第 7 章腫瘤信息系統 (OIS) 市場:按產品/服務分類

  • 軟件
  • 專業服務

第 8 章腫瘤信息系統 (OIS) 市場:按應用程序

  • 放射治療
  • 腫瘤學
  • 腫瘤外科

第 9 章腫瘤信息系統 (OIS) 市場:按最終用戶分類

  • 醫院/影像診斷中心
  • 消融與癌症治療中心
  • 政府機構
  • 研究設施

第 10 章腫瘤學信息系統 (OIS) 市場:按地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲

第11章競爭態勢

  • 概覽
  • 主要發展:腫瘤信息系統(OIS)的主要公司
  • 主要企業戰略/領先企業
  • 主要市場公司的收入份額分析
  • 市場排名分析
  • 競爭領導力圖譜
  • 初創企業/中小企業的競爭領導力圖譜
  • 競爭基準
  • 初創企業/小型企業競爭基準測試
  • 腫瘤信息系統 (OIS) 市場:研發費用
  • 主要公司的產品/區域足跡分析
  • 企業區域足跡
  • 競爭形勢和趨勢

第 12 章公司簡介

  • 主要公司
    • KONINKLIJKE PHILIPS N.V.
    • SIEMENS HEALTHINEERS
    • ELEKTA
    • GE HEALTHCARE
    • MCKESSON CORPORATION
  • 其他企業
    • CERNER CORPORATION
    • ACCURAY INCORPORATED
    • ALLSCRIPTS HEALTHCARE, LLC
    • IBM
    • F. HOFFMANN-LA ROCHE AG
    • EPIC SYSTEMS CORPORATION
    • RAYSEARCH LABORATORIES
    • CUREMD HEALTHCARE
    • BOGARDUS MEDICAL SYSTEMS, INC.
    • OPTUM (UNITEDHEALTH GROUP)
    • MICA INFORMATION SYSTEMS, INC.
    • ADVANCED DATA SYSTEMS
    • ENDOSOFT LLC
    • ALTAI ONCOLOGY, LLC
    • MIM SOFTWARE INC.

第13章 附錄

目錄
Product Code: HIT 3267

Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient. Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions to curtail the increasing cost of care and growing cases of cancer is expected to witness strong growth during forecasted period. For instance, as per National Cancer Institute, by 2040, the new cancer cases will rise by 29.5 million and the number of cancer related deaths to 16.4 million per year. Moreover, development of wide range of novel technologies will bring significant opportunities for oncology information system market during the forecast period.

"The Software segment held the largest share during the forecast period."

Software segment accounted for 83.6% of the oncology information system market for product and services in 2021. Software is a non-tangible component used to run a system or perform primary tasks, which include maintaining patient records and performing treatment planning in any healthcare organization or hospital. It is an integral part of the HCIT market and works as an interface between the database and end users. Healthcare organizations are moving from on-premise models to web- and cloud-based models, which fuels the growth of this segment during the forecast period.

"Radiation oncology segment held the largest share during the forecast period."

In 2021, the radiation oncology segment accounted for 53.8% of the oncology information system market for application. Radiation oncology specializes in treating cancer with radiation-delivering a high radiation dose directly to the tumor to kill cancer cells with minimum exposure to healthy tissue that surrounds the tumor. This limits complications, side-effects, and secondary effects to healthy tissues, which is driving advancements in radiation oncology. Some of the novel radiation oncology therapies that are widely used include external beam radiation therapy (EBRT), internal beam radiation therapy (IBRT), intraoperative radiation therapy (IORT), and brachytherapy. Integration of radiotherapy system with OIS enables clinicians to accelerate radiation dose calculation speed and improve the overall treatment planning efficiency.

"The hospitals and diagnostic imaging centers segment held the largest share during the forecast period."

In 2021, hospitals and diagnostic imaging centers accounted for 64.5% of the oncology information system market. Hospitals are the largest end-users of oncology information systems owing to the significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems, increasing number of cancer care procedures, and the growing adoption of oncology treatment care. Growing burden of various types of cancers, and increasing number of diagnostic procedures performed globally are some of the factors driving the growth for diagnostic imagaing centers in oncology information system market.

"Asia Pacific projected to grow at the highest CAGR during the forecast period."

In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the increasing investment for advancement of healthcare IT infrastructure, and increasing government support for implementation of healthcare IT solutions in healthcare settings. According to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the oncology information system market.

By Company Type: Tier 1: 46%, Tier 2: 33%, and Tier 3: 21%

By Designation: C-level Executives: 43%, Directors: 35%, and Others: 22%

By Region: North America: 30%, Europe: 35%, APAC: 24%, Latin America: 14% and Middle East & Africa: 4%

Prominent players in the oncology information system market are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US), IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).

Research Coverage:

This report describes and studies the global oncology information system market based product and services, application, end user and regional level. It provides detailed information regarding the major factors influencing the growth of this market. The report includes an in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments, and MNM overview.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall oncology information system market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

This report provides insights on:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the oncology information system market. The report analyzes this market by product and services, application, end user and region.
  • Market Development: Comprehensive information on the lucrative emerging markets, by product and services, application, end user and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the oncology information system market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the oncology information system market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 SECONDARY RESEARCH
    • 2.1.3 PRIMARY RESEARCH
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.3.1 Key data from primary sources
    • FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
      • 2.1.3.2 Breakdown of primary sources
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 6 PRIMARY SOURCES
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH
    • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 10 ONCOLOGY INFORMATION SYSTEMS MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION
    • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022-2027)
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 20 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 21 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET

4 PREMIUM INSIGHTS

  • 4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW
    • FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
  • 4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022-2027)
    • FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY APPLICATION AND COUNTRY (2021)
    • FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
  • 4.4 ONCOLOGY INFORMATION SYSTEMS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)
    • FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • 4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Need to curtail oncology care costs
    • FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015-2021 (USD BILLION)
      • 5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
    • FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019)
      • 5.2.1.3 Increasing incidence and prevalence of cancer
    • TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016-2020
      • 5.2.1.4 Favorable government mandates and support for oncology information systems
      • 5.2.1.5 Potential benefits of and technological advancements in oncology information systems
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Interoperability issues
      • 5.2.2.2 Dearth of skilled IT professionals in healthcare industry
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing healthcare IT Industry
      • 5.2.3.2 Integration of EMR with treatment planning systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Concerns regarding data privacy

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
    • 6.2.1 ARTIFICIAL INTELLIGENCE
    • 6.2.2 MACHINE LEARNING
    • 6.2.3 INTERNET OF THINGS
    • 6.2.4 BLOCKCHAIN
  • 6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
  • 6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEMS MARKET
    • FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM
  • 6.5 REGULATORY ANALYSIS
    • 6.5.1 NORTH AMERICA
    • 6.5.2 EUROPE
    • 6.5.3 ASIA PACIFIC
    • 6.5.4 MIDDLE EAST & AFRICA
    • 6.5.5 LATIN AMERICA
  • 6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.7 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEMS MARKET
    • TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.7.1 THREAT OF NEW ENTRANTS
    • 6.7.2 THREAT OF SUBSTITUTES
    • 6.7.3 BARGAINING POWER OF SUPPLIERS
    • 6.7.4 BARGAINING POWER OF BUYERS
    • 6.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS
    • TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
  • 6.9 KEY BUYING CRITERIA BY END USERS
    • FIGURE 34 BUYING CRITERIA OF END USERS
    • TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • 6.10 PATENT ANALYSIS
    • 6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS
    • FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018-2022
    • 6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS
    • FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018-2022
  • 6.11 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEMS MARKET

7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
  • 7.2 SOFTWARE
    • TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.1 PATIENT INFORMATION SYSTEMS
    • TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.1.1 Oncology electronic medical records
        • 7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries
    • TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS
    • TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.1.2 Laboratory information systems
        • 7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
    • TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS
    • TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.1.3 Radiology information systems
        • 7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders
    • TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS
    • TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.1.4 Chemotherapy information systems
        • 7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types
    • TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS
    • TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.2 TREATMENT PLANNING SYSTEMS
    • TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.2.1 Radiotherapy treatment planning systems
        • 7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors
    • TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS
    • TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.2.2 Clinical decision support systems
        • 7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS
    • TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS
    • TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.2.3 Brachytherapy treatment planning systems
        • 7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems
    • TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS
    • TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.3.1 Population health management solutions
        • 7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers
    • TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS
    • TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.3.2 Clinical integration solutions
        • 7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth
    • TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS
    • TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions
        • 7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions
    • TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS
    • TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.3.4 Advanced visualization & image analysis solutions
        • 7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth
    • TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • 7.2.3.5 Radiation dose management solutions
        • 7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management
    • TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS
    • TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 PROFESSIONAL SERVICES
    • TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.1 IMPLEMENTATION SERVICES
      • 7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services
    • TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES
    • TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.2 POST-SALE & MAINTENANCE SERVICES
      • 7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services
    • TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES
    • TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.3 CONSULTING & OPTIMIZATION SERVICES
      • 7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions
    • TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES
    • TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 52 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 RADIATION ONCOLOGY
    • 8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH
    • TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016-2030 (THOUSAND)
    • TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET
    • TABLE 55 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 MEDICAL ONCOLOGY
    • 8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
    • TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET
    • FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012-2018
    • TABLE 57 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 SURGICAL ONCOLOGY
    • 8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH
    • TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET
    • TABLE 59 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)

9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS
    • 9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
    • TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021)
    • TABLE 62 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 ABLATION & CANCER CARE CENTERS
    • 9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH
    • TABLE 63 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.4 GOVERNMENT INSTITUTES
    • 9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
    • TABLE 64 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.5 RESEARCH FACILITIES
    • 9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH
    • TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION)

10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 38 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 66 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
    • TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth
    • FIGURE 40 US: HOSPITAL EHR ADOPTION (2010-2018)
    • TABLE 76 US: KEY MACROINDICATORS
    • TABLE 77 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada
    • FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS, 2013-2018
    • TABLE 83 CANADA: KEY MACROINDICATORS
    • TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012-2030
    • TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany
    • TABLE 99 GERMANY: KEY MACROINDICATORS
    • TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs
    • TABLE 106 UK: KEY MACROINDICATORS
    • TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing reforms in digital health will support market growth
    • TABLE 113 FRANCE: KEY MACROINDICATORS
    • TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing government initiatives and reforms to drive market growth
    • TABLE 120 ITALY: KEY MACROINDICATORS
    • TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems
    • TABLE 127 SPAIN: KEY MACROINDICATORS
    • TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
    • TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Japan dominates Asia Pacific oncology information systems market
    • TABLE 149 JAPAN: KEY MACROINDICATORS
    • TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Strong government support in China to propel market growth
    • TABLE 156 CHINA: KEY MACROINDICATORS
    • TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India
    • TABLE 163 INDIA: KEY MACROINDICATORS
    • TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth
    • TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth
    • TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Modernization of healthcare infrastructure to drive market growth
    • TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth
    • TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
    • TABLE 215 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 216 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 217 MIDDLE EAST & AFRICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 MIDDLE EAST & AFRICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 219 MIDDLE EAST & AFRICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 222 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY DEVELOPMENTS BY LEADING PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET, JANUARY 2018-APRIL 2022
  • 11.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 44 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • TABLE 223 ONCOLOGY INFORMATION SYSTEMS MARKET: DEGREE OF COMPETITION
  • 11.5 MARKET RANKING ANALYSIS
    • FIGURE 45 RANK OF COMPANIES IN GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET (2021)
  • 11.6 COMPETITIVE LEADERSHIP MAPPING
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 46 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
  • 11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
    • FIGURE 47 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
  • 11.8 COMPETITIVE BENCHMARKING
    • TABLE 224 ONCOLOGY INFORMATION SYSTEMS MARKET: SUPPORTING DATA OF KEY START-UPS/SMES
  • 11.9 COMPETITIVE BENCHMARKING FOR STARTUPS/SMES
    • TABLE 225 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 11.10 ONCOLOGY INFORMATION SYSTEMS MARKET: R&D EXPENDITURE
    • FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET (2020 VS. 2021)
  • 11.11 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
    • FIGURE 49 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET
  • 11.12 COMPANY REGIONAL FOOTPRINT
    • TABLE 226 COMPANY REGIONAL FOOTPRINT
    • TABLE 227 COMPANY SOFTWARE FOOTPRINT
    • TABLE 228 COMPANY SERVICE FOOTPRINT
    • TABLE 229 COMPANY APPLICATION FOOTPRINT
  • 11.13 COMPETITIVE SITUATION AND TRENDS
    • 11.13.1 PRODUCT LAUNCHES
    • TABLE 230 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY PRODUCT LAUNCHES
    • 11.13.2 DEALS
    • TABLE 231 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY DEALS
    • 11.13.3 OTHER DEVELOPMENTS
    • TABLE 232 ONCOLOGY INFORMATION SYSTEMS MARKET: OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 KONINKLIJKE PHILIPS N.V.
    • TABLE 233 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
    • 12.1.2 SIEMENS HEALTHINEERS
    • TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
    • 12.1.3 ELEKTA
    • TABLE 235 ELEKTA: BUSINESS OVERVIEW
    • FIGURE 52 ELEKTA: COMPANY SNAPSHOT (2021)
    • 12.1.4 GE HEALTHCARE
    • TABLE 236 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 12.1.5 MCKESSON CORPORATION
    • TABLE 237 MCKESSON CORPORATION: BUSINESS OVERVIEW
    • FIGURE 54 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
  • 12.2 OTHER PLAYERS
    • 12.2.1 CERNER CORPORATION
    • TABLE 238 CERNER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 55 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.2.2 ACCURAY INCORPORATED
    • TABLE 239 ACCURAY INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 56 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021)
    • 12.2.3 ALLSCRIPTS HEALTHCARE, LLC
    • TABLE 240 ALLSCRIPTS HEALTHCARE, LLC.: BUSINESS OVERVIEW
    • FIGURE 57 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
    • 12.2.4 IBM
    • TABLE 241 IBM: BUSINESS OVERVIEW
    • FIGURE 58 IBM: COMPANY SNAPSHOT (2021)
    • 12.2.5 F. HOFFMANN-LA ROCHE AG
    • TABLE 242 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
    • FIGURE 59 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
    • 12.2.6 EPIC SYSTEMS CORPORATION
    • TABLE 243 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
    • 12.2.7 RAYSEARCH LABORATORIES
    • TABLE 244 RAYSEARCH LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 60 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2021)
    • 12.2.8 CUREMD HEALTHCARE
    • TABLE 245 CUREMD HEALTHCARE: BUSINESS OVERVIEW
    • 12.2.9 BOGARDUS MEDICAL SYSTEMS, INC.
    • TABLE 246 BOGARDUS MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
    • 12.2.10 OPTUM (UNITEDHEALTH GROUP)
    • TABLE 247 OPTUM: BUSINESS OVERVIEW
    • FIGURE 61 OPTUM: COMPANY SNAPSHOT (2021)
    • 12.2.11 MICA INFORMATION SYSTEMS, INC.
    • TABLE 248 MICA INFORMATION SYSTEMS, INC.: BUSINESS OVERVIEW
    • 12.2.12 ADVANCED DATA SYSTEMS
    • TABLE 249 ADVANCED DATA SYSTEMS: BUSINESS OVERVIEW
    • 12.2.13 ENDOSOFT LLC
    • TABLE 250 ENDOSOFT LLC: BUSINESS OVERVIEW
    • 12.2.14 ALTAI ONCOLOGY, LLC
    • TABLE 251 ALTAI ONCOLOGY, LLC: BUSINESS OVERVIEW
    • 12.2.15 MIM SOFTWARE INC.
    • TABLE 252 MIM SOFTWARE INC.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS